AI-enabled drug design

Technology-enabled pharmaceutical company

This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

Avicenna Biosciences

The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.

Variartional

This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.

DeepMirror AI

This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.

Variational AI

The company develops a generative artificial intelligence platform for small molecule drug discovery for biopharmaceutical and biotechnology organisations.

Anagenex

This company develops a machine learning and biochemistry platform to identify and optimise small molecule drug candidates for pharmaceutical and biotechnology organisations.